Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DLO NYSE:HIMS NASDAQ:TEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDLODLocal$14.60-1.8%$12.93$7.61▼$16.44$4.65B1.133.01 million shs1.98 million shsHIMSHims & Hers Health$53.31-4.8%$50.97$16.05▼$72.98$12.66B2.1427.14 million shs23.21 million shsTEMTempus AI$79.23-5.8%$71.97$31.36▼$97.79$14.62B5.088.78 million shs9.66 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDLODLocal-2.30%+1.57%+1.71%+35.30%+83.58%HIMSHims & Hers Health-3.29%+9.91%+25.46%+34.95%+240.45%TEMTempus AI-2.03%-3.34%+4.48%+28.50%+51.97%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDLODLocal$14.60-1.8%$12.93$7.61▼$16.44$4.65B1.133.01 million shs1.98 million shsHIMSHims & Hers Health$53.31-4.8%$50.97$16.05▼$72.98$12.66B2.1427.14 million shs23.21 million shsTEMTempus AI$79.23-5.8%$71.97$31.36▼$97.79$14.62B5.088.78 million shs9.66 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDLODLocal-2.30%+1.57%+1.71%+35.30%+83.58%HIMSHims & Hers Health-3.29%+9.91%+25.46%+34.95%+240.45%TEMTempus AI-2.03%-3.34%+4.48%+28.50%+51.97%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDLODLocal 2.60Moderate Buy$14.00-4.11% DownsideHIMSHims & Hers Health 1.92Reduce$38.92-27.00% DownsideTEMTempus AI 2.54Moderate Buy$70.17-11.44% DownsideCurrent Analyst Ratings BreakdownLatest HIMS, DLO, and TEM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/16/2025DLODLocalCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$14.60 ➝ $17.009/12/2025HIMSHims & Hers HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$68.009/12/2025TEMTempus AIHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$90.00 ➝ $98.009/2/2025TEMTempus AIHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$90.008/22/2025DLODLocalTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$12.00 ➝ $14.008/20/2025TEMTempus AIBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$75.00 ➝ $85.008/19/2025HIMSHims & Hers HealthZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/18/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$48.00 ➝ $37.008/14/2025DLODLocalMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$15.008/14/2025DLODLocalHSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$11.50 ➝ $15.008/14/2025DLODLocalHsbc Global ResSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy(Data available from 9/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDLODLocal$745.97M6.12$0.59 per share24.54$1.71 per share8.54HIMSHims & Hers Health$1.48B8.16$0.34 per share159.02$2.16 per share24.68TEMTempus AI$693.40M19.85N/AN/A$0.35 per share226.37Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDLODLocal$120.42M$0.4830.4225.61N/A16.90%36.85%14.87%11/12/2025 (Estimated)HIMSHims & Hers Health$126.04M$0.8066.64102.523.789.63%26.26%13.06%11/3/2025 (Estimated)TEMTempus AI-$705.81M-$1.19N/AN/AN/A-20.98%-122.86%-18.09%11/3/2025 (Estimated)Latest HIMS, DLO, and TEM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025DLODLocal$0.13$0.14+$0.01$0.14$226.71 million$256.50 million8/8/2025Q2 2025TEMTempus AI-$0.23-$0.22+$0.01-$0.25$296.84 million$314.64 million8/4/2025Q2 2025HIMSHims & Hers Health$0.18$0.17-$0.01$0.17$550.06 million$544.83 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDLODLocalN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/ATEMTempus AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDLODLocal0.011.461.46HIMSHims & Hers Health1.724.984.46TEMTempus AI2.581.541.43Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDLODLocal90.13%HIMSHims & Hers Health63.52%TEMTempus AI24.22%Insider OwnershipCompanyInsider OwnershipDLODLocal45.44%HIMSHims & Hers Health13.71%TEMTempus AI26.27%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDLODLocal1,095312.46 million170.48 millionOptionableHIMSHims & Hers Health1,637226.02 million195.03 millionOptionableTEMTempus AI2,400173.73 million128.09 millionN/AHIMS, DLO, and TEM HeadlinesRecent News About These CompaniesTempus AI Enhances Cancer Research Tools With FDA-Cleared xR IVDSeptember 23 at 9:35 AM | zacks.comTempus AI (NASDAQ:TEM) Hits New 12-Month High - Time to Buy?September 23 at 5:37 AM | marketbeat.comVoya Investment Management LLC Purchases Shares of 35,585 Tempus AI, Inc. $TEMSeptember 23 at 3:03 AM | marketbeat.comIBD 50's Tempus AI Pulls Back From Record High After Another FDA ClearanceSeptember 22 at 11:27 PM | msn.comOverlooked Stock: TEM Taps All-Time High on FDA ClearanceSeptember 22 at 5:05 PM | youtube.comYTempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic DeviceSeptember 22 at 1:24 PM | bakersfield.comBTempus AI Shares Up After FDA Clearance for In Vitro Diagnostic DeviceSeptember 22 at 1:24 PM | marketwatch.comTempus AI stock rises after FDA clearance for RNA sequencing deviceSeptember 22 at 1:24 PM | za.investing.comIBD 50's Tempus AI Hits Record High On Yet Another FDA ClearanceSeptember 22 at 1:24 PM | msn.comBest Artificial Intelligence Stocks To Follow Now - September 22ndSeptember 22 at 1:08 PM | marketbeat.com3 Big Short Interest Names With Bullish Setups...September 22 at 12:04 PM | marketbeat.comSeaCrest Wealth Management LLC Sells 4,841 Shares of Tempus AI, Inc. $TEMSeptember 22 at 4:10 AM | marketbeat.comTempus AI Surges Since IPO as FDA Clearance Boosts Growth OutlookSeptember 21 at 10:30 AM | insidermonkey.comBouvel Investment Partners LLC Purchases New Shares in Tempus AI, Inc. $TEMSeptember 21 at 5:44 AM | marketbeat.comTempus AI, Inc. $TEM Shares Sold by Exchange Traded Concepts LLCSeptember 20, 2025 | marketbeat.comTempus AI (NASDAQ:TEM) Shares Up 1.3% - Here's What HappenedSeptember 19, 2025 | marketbeat.comKuehn Law Encourages Investors of Tempus AI, Inc. to Contact Law FirmSeptember 19, 2025 | prnewswire.comThis AI Stock Has More Than Doubled in 2025. Is It a Buy?September 19, 2025 | msn.comTempus AI awarded $60.57M contract from Dept. of Health and Human ServicesSeptember 18, 2025 | msn.comTempus AI Unusual Options Activity For September 17September 17, 2025 | benzinga.comTempus AI (TEM) Is Up 7.4% After FDA Clears Cardiac Imaging Platform for Advanced MR Analysis – Has The Bull Case Changed?September 17, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesNIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 20253 Fintech Stocks Beating the Market in 2025By Ryan Hasson | September 8, 2025Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut FrenzyBy Gabriel Osorio-Mazilli | September 21, 20253 Big Short Interest Names With Bullish SetupsBy Ryan Hasson | September 22, 20253 Heavily Shorted Stocks That Could Prove the Bears WrongBy Leo Miller | September 2, 2025HIMS, DLO, and TEM Company DescriptionsDLocal NASDAQ:DLO$14.60 -0.27 (-1.82%) Closing price 04:00 PM EasternExtended Trading$14.70 +0.10 (+0.68%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DLocal Limited operates a payment processing platform worldwide. The company offers pay-in solution which the business and get paid for their products and services through various payment methods, including international and local cards, online bank transfers and direct debit, cash, and alternative payment methods. It also provides pay-out solution used for merchants to scale pay-out operations. In addition, the company offers dLocal for Platforms, an end-to-end payment solution that offers a range of services to help platforms manage payments. It serves its products to commerce, streaming, ride-hailing, financial services, advertising, SaaS, travel, e-learning, on-demand delivery, and gaming and crypto industries. DLocal Limited was founded in 2016 and is headquartered in Montevideo, Uruguay.Hims & Hers Health NYSE:HIMS$53.31 -2.69 (-4.81%) Closing price 03:59 PM EasternExtended Trading$53.46 +0.15 (+0.28%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.Tempus AI NASDAQ:TEM$79.23 -4.90 (-5.82%) Closing price 04:00 PM EasternExtended Trading$80.45 +1.22 (+1.54%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Qualcomm’s RSI Just Hit Its High of the Year—Why That’s Bullish 2 Ways to Trade Amazon Ahead of October’s Prime Day AutoZone Pulls Into a Buy-the-Dip Opportunity Rocket Lab’s Bullish Case Remains Intact Despite Recent Offering Broadcom Price Targets Just Reached Above $400 for the First Time Replace Your Fixed Income With This Dividend ETF These 3 Mega-Cap Giants Just Increased Dividends by 7% or More Ford Set to Outpace GM With Tariff Tailwinds and EPS Momentum Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
